ABSTRACT The use of invasive coronary physiology to select individuals for coronary revascularization has been established in current guidelines for the management of stable coronary artery disease. Compared to angiography alone, coronary physiology has been proven to improve clinical outcomes and cost-effectiveness in the revascularization process. Randomized controlled trials, however, have questioned the efficacy of ischemia testing in selecting individuals for revascularization. After an angiographically successful percutaneous coronary intervention, 20 to 40% of patients experienced persistent or recurrent angina. Artificial […]
